Table 2 Anticancer activity results.

From: Design and efficient synthesis of pyrazoline and isoxazole bridged indole C-glycoside hybrids as potential anticancer agents

Compounds

Cell Viability (%) ± SD

Compounds

Cell Viability (%) ± SD

50 µM

25 µM

10 µM

50 µM

25 µM

10 µM

9

36.32 ± 4.29

54.03 ± 11.19

71.14 ± 10.53

27

97.74 ± 10.12

90.81 ± 7.09

90.05 ± 7.70

10

85.37 ± 14.16

84.49 ± 6.74

91.40 ± 10.38

28

63.36 ± 17.49

95.16 ± 13.62

99.50 ± 10.20

11

107.54 ± 2.89

100.13 ± 8.93

100.25 ± 23.01

29

73.55 ± 8.45

76.56 ± 6.58

82.22 ± 7.65

12

74.75 ± 7.02

89.80 ± 8.75

79.24 ± 8.51

30

87.98 ± 1.10

92.06 ± 8.00

93.84 ± 5.85

13

84.22 ± 9.22

94.24 ± 1.96

97.58 ± 2.25

31

87.57 ± 6.27

90.13 ± 6.77

91.41 ± 3.62

14

60.56 ± 5.61

58.98 ± 12.47

73.61 ± 11.76

32

66.54 ± 7.27

78.49 ± 4.44

74.63 ± 4.70

15

67.46 ± 17.69

113.07 ± 23.87

125.13 ± 3.51

33

92.63 ± 15.25

106.38 ± 7.40

103.51 ± 12.72

16

56.70 ± 17.82

89.59 ± 12.91

75.04 ± 14.31

34

43.40 ± 0.26

46.10 ± 3.32

68.37 ± 5.36

17

79.43 ± 10.36

80.48 ± 2.58

84.10 ± 4.09

35

93.89 ± 9.08

95.31 ± 3.60

95.45 ± 4.91

18

69.81 ± 20.40

78.47 ± 6.73

71.68 ± 28.36

36

99.33 ± 4.28

96.80 ± 11.58

97.84 ± 11.61

19

71.48 ± 6.24

89.20 ± 28.63

102.51 ± 10.39

37

64.41 ± 7.77

76.39 ± 10.41

74.75 ± 10.73

20

61.98 ± 4.91

54.28 ± 16.32

56.70 ± 23.23

38

94.90 ± 4.49

94.45 ± 3.67

99.10 ± 5.63

21

75.04 ± 2.62

76.76 ± 2.43

73.46 ± 2.43

39

90.31 ± 2.88

89.42 ± 5.32

120.42 ± 17.62

22

70.33 ± 6.17

68.62 ± 11.05

70.40 ± 12.97

40

87.93 ± 4.71

96.03 ± 1.81

93.70 ± 2.68

23

81.53 ± 5.45

88.82 ± 2.22

104.77 ± 11.28

41

73.96 ± 17.57

81.22 ± 5.17

89.23 ± 3.70

24

77.74 ± 2.56

77.51 ± 8.96

82.23 ± 3.50

42

95.23 ± 13.64

93.37 ± 15.68

92.62 ± 11.51

25

43.82 ± 13.04

54.17 ± 7.06

97.58 ± 3.36

43

95.70 ± 3.26

85.24 ± 2.93

96.59 ± 3.98

26

99.50 ± 1.88

98.25 ± 0.34

100.58 ± 9.67

44

81.68 ± 3.45

82.94 ± 5.28

83.90 ± 4.08

YM155 (20 nM)

27.39 ± 4.93

  

Menadione (20 µM)

20.77 ± 8.70